Dr. Martens plc is a British public limited company renowned for its iconic footwear and accessories brand. Originating from the first '1460' boot crafted on 1 April 1960 in Wollaston, England, the co... Dr. Martens plc is a British public limited company renowned for its iconic footwear and accessories brand. Originating from the first '1460' boot crafted on 1 April 1960 in Wollaston, England, the company has grown into one of the world's most recognized footwear brands, symbolizing individual self-expression for a diverse consumer base. Its product segments encompass Originals, Fusion, Kids and Casual lines, alongside boots, shoes, sandals, and complementary bags and accessories, distinguished by air-cushioned soles, unique upper shapes, welted construction, and signature yellow stitching. Dr. Martens plc distributes through e-commerce, retail stores (including 239 owned worldwide), and wholesale channels, operating in over 60 countries across three key regions: EMEA (majority revenue source), Americas, and APAC. With a workforce of approximately 3,700 employees and headquarters in Camden, London, the company maintains limited UK production at its historic Cobbs Lane factory while manufacturing primarily in Asia. As a FTSE 250 constituent listed since January 2021, Dr. Martens plc plays a significant role in the consumer cyclical sector, particularly footwear and accessories, annually selling over 10.5 million pairs and deriving 65% of revenue from direct-to-consumer sales.
Financial Fundamentals data not yet covered for Dr Martens
We have not yet reviewed Dr Martens's disclosures for Financial Fundamentals data.
If this data is relevant to your work, you can submit a data coverage request and our team
will investigate the company's disclosures and capture the data if available.